Clarity Submitv1.0.0

Researchers submit protein variants linked to diseases like ALS or Alzheimer's for automated structural prediction. This accelerates hypothesis testing by validating feasibility and queuing folds without manual setup, enabling focus on experimental validation.

Drug discovery teams investigate mutations in target proteins to understand structural impacts on drug binding. By programmatically submitting variants, they integrate Clarity Protocol into pipelines for high-throughput analysis of variants of interest.

Companies analyze patient genetic data and submit identified variants for structural insights. This adds value by providing predictive folding results to clinicians, helping interpret variants of uncertain significance in diseases like frontotemporal dementia.

Developers integrate the skill into custom software or agents for automated hypothesis submission. This enables batch processing of variants from databases, enhancing tools with AI-driven validation and folding capabilities for users.

Offer access to Clarity Protocol's validation and folding via API keys, charging per submission or through tiered plans. Revenue comes from research institutions and companies needing scalable protein analysis without in-house infrastructure.

Monetize the structural prediction data generated from submissions by licensing aggregated results to biotech firms or academic consortia. This creates recurring revenue from insights into protein variants and disease mechanisms.

Partner with genetic analysis platforms or lab software to embed the skill directly, earning revenue through referral fees or revenue sharing. This expands reach by making submission seamless within existing research workflows.